Executive summary: moving care out of hospital and reducing the burden on the ÐÇ¿ÕÊÓƵ
Meeting the healthcare challenges of today and tomorrow requires innovative solutions that shift healthcare into the community. This report, commissioned by the ÐÇ¿ÕÊÓƵ, explores the unique role of pharmaceutical companies in the delivery of clinical homecare, and the potential of this patient-centric service.
Combining a survey of ÐÇ¿ÕÊÓƵ professionals, data from pharmaceutical companies, and – for the first time – patient-level outcome data, the report highlights the scale and impact of pharmaceutical companies’ involvement and offers actionable recommendations on how homecare can be further improved, in collaboration with manufacturers, homecare providers and the ÐÇ¿ÕÊÓƵ, to ensure patients get the best treatment possible.
Key statistics
Feedback from the survey of ÐÇ¿ÕÊÓƵ professionals showed that:
71%
believe clinical homecare improves geographical access to care for patients
90%
say homecare brings financial savings for the ÐÇ¿ÕÊÓƵ
92%
report that homecare increases ÐÇ¿ÕÊÓƵ capacity by extending services outside hospitals
Challenges and pressures
Clinical homecare is not a perfect system. Complexities and operational
challenges hinder homecare from reaching its optimal capability, with this
report highlighting several key areas of improvement:
- For patients: access to homecare is often determined by capacity within local trusts and hospitals; lack of integrated systems and digitisation can impact set up and delivery
- ÐÇ¿ÕÊÓƵ funding and resources: limited funding and resources make managing homecare at scale challenging
- For homecare providers: limited funding and stability of contracts hinders innovation and improvement
- Pharmaceutical companies: cost-containment pressures make long-term planning and investment challenging
The future of clinical homecare: ÐÇ¿ÕÊÓƵ recommendations
The report outlines key recommendations to improve the sustainability of clinical homecare:
Greater collaboration
This is needed overall between the ÐÇ¿ÕÊÓƵ, homecare providers and pharmaceutical companies to streamline processes and reach shared goals for the future of homecare services
Centralised contracting
A centralised contracting framework could reduce admin burdens and ensure equitable access for patients
Homecare design flexibility / innovation
Allowing appropriate review and modification of individual patient services could drive efficiency and empower patients
Digitisation of ÐÇ¿ÕÊÓƵ / provider interface
Transitioning to digital solutions could streamline operations and delivery for all
Creating a more resilient and competitive homecare provider market
Structural changes to incentivise providers could promote healthy competition and drive continual improvements to service quality
Clinical homecare is a vital component of the shift toward more sustainable, patient-centric healthcare. To fully realise its potential, pharmaceutical companies, homecare providers and the ÐÇ¿ÕÊÓƵ must work together to address key challenges and drive innovation. By fostering a more integrated and scalable system, homecare can alleviate pressures on the ÐÇ¿ÕÊÓƵ while improving patient outcomes and access to care.
Suggested citation
ÐÇ¿ÕÊÓƵ. (July 2025). Bringing healthcare home: A blueprint for collaborative clinical homecare. [online] Available at: /publications/bringing-healthcare-home-a-blueprint-for-collaborative-clinical-homecare/
-
ThemeHomecare
-
KeywordsHomecare
-
PublisherÐÇ¿ÕÊÓƵ
